IP Library Assignment 032738/0571
Patent Assignment
Reel/Frame 032738/0571

Assignment of Assignor's Interest

Recorded: 2014-04-23 Pages: 6
Assignors
ECONOMIDES, ARIS N.
Executed: 2014-01-16
VALENZUELA, DAVID M.
Executed: 2014-01-14
Assignee
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NEW YORK, 10591-6707
Covered Properties (18)
Methods of Modifying Eukaryotic Cells
Patent: 6,596,541 →
Application: 09/784,859 →
Publication: US 2002/0106629
Methods of Modifying Eukaryotic Cells
Patent: 7,105,348 →
Application: 10/076,840 →
Publication: US 2002/0183275
Hybrid Antibodies Comprising Human Variable Regions and Mouse Constant Regions Produced in a Genetically Modified Mouse
Patent: 8,791,323 →
Application: 11/595,427 →
Publication: US 2007/0061900
Methods of Producing Hybrid Antibodies
Patent: 9,376,699 →
Application: 13/154,976 →
Publication: US 2011/0258710
Methods Of Making A Nucleic Acid Encoding A Human Variable Region
Patent: 9,708,635 →
Application: 13/719,819 →
Publication: US 2013/0210137
Methods of Modifying Eurakyotic Cells
Application: 13/719,842 →
Publication: US 2013/0130388
Methods of Making a Nucleic Acid Encoding a Human Variable Region
Application: 14/035,432 →
Publication: US 2014/0023637
Methods of Producing Hybrid Antibodies
Patent: 9,388,446 →
Application: 14/036,514 →
Publication: US 2014/0017238
Mice That Produce Hybrid Antibodies
Application: 14/036,518 →
Publication: US 2014/0013457
Methods of Producing Hybrid Antibodies
Patent: 9,382,567 →
Application: 14/036,530 →
Publication: US 2014/0017229
Mouse Embryonic Stem Cells Comprising a Hybrid Heavy Chain Immunoglobulin Locus
Application: 14/036,774 →
Publication: US 2014/0017781
Mice That Produce Hybrid Antibodies
Application: 14/036,778 →
Publication: US 2014/0020124
Mice That Produce Hybrid Antibodies
Application: 14/036,784 →
Publication: US 2014/0020125
Cells Expressing Hybrid Antibodies
Application: 14/036,865 →
Publication: US 2014/0017782
Methods of Modifying Eukaryotic Cells
Patent: 9,528,136 →
Application: 14/036,892 →
Publication: US 2014/0018522
Genetically Modified Mice That Produce Hybrid Antibodies
Patent: 9,371,553 →
Application: 14/046,279 →
Publication: US 2014/0033337
Mice that produce hybrid antibodies
Application: 14/046,285 →
Publication: US 2014/0033336
Methods of Producing Hybrid Antibodies
Patent: 9,353,394 →
Application: 14/080,114 →
Publication: US 2014/0073010
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 11, 2001
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 011880/0206 →
Assignment of Assignor's Interest May 31, 2002
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 012948/0133 →
Assignment of Assignor's Interest Nov 9, 2006
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 018566/0497 →
Assignment of Assignor's Interest Mar 22, 2013
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS INC.
Reel/Frame 030068/0356 →
Assignment of Assignor's Interest Aug 28, 2013
From: KAROW, MARGARET; MACDONALD, LYNN; STEVENS, SEAN
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 031100/0121 →
Assignment of Assignor's Interest Nov 8, 2013
From: MURPHY, ANDREW; YANCOPOULOS, GEORGE D.
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 031568/0835 →
Assignment of Assignor's Interest Mar 5, 2014
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.; KAROW, MARGARET; MACDONALD, LYNN
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 032356/0833 →
Assignment of Assignor's Interest Mar 11, 2014
From: MURPHY, ANDREW J.; YANCOPOULOS, GEORGE D.; KAROW, MARGARET; MACDONALD, LYNN
To: REGENERON PHARMACEUTICALS INC.
Reel/Frame 032406/0956 →